{"id":164,"date":"2022-12-29T12:57:00","date_gmt":"2022-12-29T11:57:00","guid":{"rendered":"https:\/\/www.site.cdcl.xyz\/2022\/12\/29\/article-tout-frais-justice-department-sues-major-drug-distributor-over-opioid-epidemic\/"},"modified":"2022-12-29T12:57:00","modified_gmt":"2022-12-29T11:57:00","slug":"article-tout-frais-justice-department-sues-major-drug-distributor-over-opioid-epidemic","status":"publish","type":"post","link":"https:\/\/www.centresaintebarbe.fr\/blog\/article-tout-frais-justice-department-sues-major-drug-distributor-over-opioid-epidemic\/","title":{"rendered":"Article tout frais : Justice Department sues major drug distributor over opioid epidemic"},"content":{"rendered":"

Cet article, dont le sujet est \u00ab la justice \u00bb, vient d\u2019\u00eatre vu sur le web, nous sommes heureux de vous en produire l\u2019essentiel dans cette publication.<\/p>\n

Son titre troublant (Justice Department sues major drug distributor over opioid epidemic) est parlant.<\/p>\n

Annonc\u00e9 sous la signature \u00abd\u2019anonymat
\u00bb, l\u2019\u00e9ditorialiste est positivement connu.<\/p>\n

Il n\u2019y a pas de raison de douter de la fiabilit\u00e9 de ces informations.<\/p>\n

L\u2019article a \u00e9t\u00e9 publi\u00e9 \u00e0 une date mentionn\u00e9e 2022-12-29 12:57:00.<\/p>\n

Voici ll\u2019article dont il s\u2019agit : <\/p>\n

\n

The Department of Justice (DOJ) sued one of the nation\u2019s largest drug distributors on Thursday, accusing the company of partially fueling the opioid crisis by failing to report hundreds of thousands of suspicious orders.<\/p>\n

The civil complaint against AmerisourceBergen, filed in federal court in the Eastern District of Pennsylvania, asks for potentially billions of dollars in financial penalties against the firm based on alleged violations of the Controlled Substances Act that federal prosecutors say date back to 2014.<\/p>\n

\u201cThe Department of Justice is committed to holding accountable those who fueled the opioid crisis by flouting the law,\u201d Associate Attorney General Vanita Gupta said in a statement. \u201cCompanies distributing opioids are required to report suspicious orders to federal law enforcement. Our complaint alleges that AmerisourceBergen \u2014 which sold billions of units of prescription opioids over the past decade \u2014 repeatedly failed to comply with that requirement.\u201d<\/p>\n

The complaint in particular singles out several pharmacies that prosecutors alleged demonstrate how AmerisourceBergen was aware of \u201cred flags\u201d of their product being diverted to illegal markets, arguing the company continued to sell product anyways and did not properly report the suspicions.<\/p>\n

Prosecutors alleged AmerisourceBergen continued to send drugs to two pharmacies even after it became aware their product was likely being sold in parking lots for cash.<\/p>\n

The complaint also details AmerisourceBergen\u2019s alleged sales to one pharmacy that pleaded guilty to unlawfully selling controlled substances, another whose pharmacist-in-charge was indicted for alleged drug diversion and another that the company identified was distributing drugs to 11 patients who were potentially addicted to drugs.<\/p>\n

AmerisourceBergen pushed back on those examples, arguing the blame should instead be placed on the Drug Enforcement Agency (DEA).<\/p>\n

\u201cIn each of these examples \u2014 which were cherry picked by DOJ from the thousands of pharmacies AmerisourceBergen delivers medicines to be the most incriminating to the company \u2014 the DEA received information directly from AmerisourceBergen on the pharmacy and its ordering of controlled substances like opioids,\u201d the company said in a statement.<\/p>\n